PhiloGene's VEGFb granted orphan drug status in US for advanced melanoma.

Source: Inpharma, Volume 1, Number 1648, 2008-07-26 , pp. 23-23(1)

Publisher: Adis International

Keywords: Angiogenesis-inhibitors, therapeutic use; Development-status; Malignant-melanoma, treatment; Orphan-drugs; PhiloGene; Research-and-development; Vascular-endothelial-growth-factor, therapeutic us

Document Type: Short communication

Publication date: 2008-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers